Two Sigma Advisers’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,600
Closed -$120K 2723
2023
Q1
$120K Sell
32,600
-193,800
-86% -$816K ﹤0.01% 2356
2022
Q4
$401K Sell
226,400
-23,400
-9% -$62.2K ﹤0.01% 1966
2022
Q3
$989K Sell
249,800
-53,800
-18% -$331K ﹤0.01% 1526
2022
Q2
$1.68M Buy
303,600
+142,900
+89% +$1.17M ﹤0.01% 1302
2022
Q1
$2.36M Sell
160,700
-147,300
-48% -$1.97M 0.01% 1163
2021
Q4
$4.87M Buy
308,000
+190,200
+161% +$4.57M 0.01% 780
2021
Q3
$3.78M Buy
117,800
+82,900
+238% +$2.91M 0.01% 922
2021
Q2
$1.45M Buy
+34,900
New +$1.43M ﹤0.01% 1459

Other funds holding DMTK

Two Sigma Advisers's DMTK Position: Q2 2023 in Review

Two Sigma Advisers sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 32,600 shares — an estimated $120K sold.

Two Sigma Advisers first reported a position in DMTK in Q2 2021 and held it in 8 quarters. The position peaked at $4.87M in Q4 2021. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

  • Two Sigma Advisers reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 32,600 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $120K.
  • Two Sigma Advisers first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Two Sigma Advisers's DermTech, Inc. Common Stock position peaked at $4.87M in Q4 2021.
  • 85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.